Does TOFACITINIB Cause Dyspnoea exertional? 171 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Dyspnoea exertional have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
171
Reports of Dyspnoea exertional with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
38
Hospitalizations
How Dangerous Is Dyspnoea exertional From TOFACITINIB?
Of the 171 reports, 1 (0.6%) resulted in death, 38 (22.2%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which TOFACITINIB Alternatives Have Lower Dyspnoea exertional Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN